Stockscreener 앱 받기
18.59
0.96%
-0.175
Ceribell Inc 주식(CBLL)의 최신 뉴스
ETF Watch: What are the risks of holding CeriBell Inc2026 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Ceribell, Inc. (CBLL) reports Q4 loss, beats revenue estimates - MSN
CeriBell, Inc. (NASDAQ:CBLL) Short Interest Update - MarketBeat
CBLL PE Ratio & Valuation, Is CBLL Overvalued - Intellectia AI
Suma receives Ceribell, Inc. accolade for breakthrough neonatal care innovation - Traders Union
Ceribell’s Woo sells $202k in shares - Investing.com Nigeria
Foehr David, senior VP at Ceribell, sells $81k in CBLL stock - Investing.com Nigeria
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium - Yahoo Finance
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot - Yahoo Finance
CBLL wins FDA breakthrough status for AI-based LVO stroke detection - MSN
Robertson sells Ceribell (CBLL) shares worth $14,720 By Investing.com - Investing.com India
CeriBell (NASDAQ:CBLL) CEO Sells $680,550.00 in Stock - MarketBeat
CeriBell (NASDAQ:CBLL) Director Rebecca Robertson Sells 827 Shares - MarketBeat
David Foehr Sells 4,560 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Robertson sells Ceribell (CBLL) shares worth $14,720 - Investing.com Nigeria
Ceribell CEO Chao sells $680k in CBLL stock By Investing.com - Investing.com Canada
Ceribell CEO Chao sells $680k in CBLL stock - Investing.com India
Ceribell Insider Sold Shares Worth $680,564, According to a Recent SEC Filing - marketscreener.com
Director at Ceribell (CBLL) sells 827 shares via Rule 10b5-1 plan - Stock Titan
Ceribell Earnings Call Highlights Strong Growth, Rising Costs - TipRanks
Ceribell’s Woo sells $202k in shares By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) CTO Sells $147,587.75 in Stock - MarketBeat
CBLL (NASDAQ: CBLL) affiliate Xingjuan Chao sells multiple blocks totaling 145,084 shares - Stock Titan
CBLL (NASDAQ: CBLL) Rule 144 notice; affiliate to sell 4,560 shares - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Insider Monkey
CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector - DirectorsTalk Interviews
CBLL Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and Option Care Health (OPCH) - The Globe and Mail
Earnings Call Summary | Ceribell(CBLL.US) Q4 2025 Earnings Conference - 富途牛牛
CeriBell (CBLL) Revenue Growth To US$24.8m Tests Premium Valuation Narrative - simplywall.st
Top Ceribell Executives Quietly Unload Shares in Coordinated Insider Move - TipRanks
Insider Selling: CeriBell (NASDAQ:CBLL) VP Sells 569 Shares of Stock - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 705 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 781 Shares - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells 808 Shares of Stock - MarketBeat
[Form 4] Ceribell, Inc. Insider Trading Activity - Stock Titan
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating - TipRanks
CeriBell (NASDAQ:CBLL) Shares Gap DownTime to Sell? - MarketBeat
Ceribell Inc. debuts AI-enabled neonatal EEG at NEO Pediatrix Conference - Traders Union
CeriBell revenue up 34% to USD 24.8M in Q4 2025 - Medical Buyer
CeriBell Q4 Revenue Rises 34%; Projects Revenue Growth Of 25%-29% For FY'26 - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
CeriBell (CBLL) Q4 2025 Earnings Call Transcript - The Globe and Mail
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating - TipRanks
CeriBell Q4 Earnings Call Highlights - Yahoo Finance
CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates - Nasdaq
CeriBell, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
CBLLCeriBell, Inc. Latest Stock News & Market Updates - Stock Titan
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook - ChartMill
1.60%
0.00%
자본화:
|
볼륨(24시간):